Poggio et al. [24] discovered that the majority of PD-L1 could be presented on the surface of TEXs, and genetic blockade of exosomal PD-L1 could activate an anti-tumor immune response leading to extend survival in a subset of cancer patients. This evidence concerns the gene CD274 and neoplasm.